Gluconic Acid

Gluconic Acid

SCHEMBL3411059

O.O.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Mg+2]

nearest known ligand 0.87

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A

The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.87
PDE4A P27815 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.50
USP2 O75604 1/20 0.48
SLCO1B1 Q9Y6L6 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
OR51E2 Q9H255 1/20 0.39
KDM4E B2RXH2 2/20 0.37
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CA4 P22748 2/20 0.31
TOP1 P11387 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gluconic Acid SCHEMBL28434410 1.00 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL505647 1.00 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL25290978 0.98 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL24660 0.98 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL28143704 0.98 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL28785788 0.95 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL9776916 0.95 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL28977317 0.95 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL21462395 0.95 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL2592769 0.95 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119113016-A Solid composition for oral administration and preparation method and application thereof 四川科瑞德食品有限公司 2024-12-13 CN claimed
CN-117281264-A Emotion-regulating composition, preparation method thereof and application of composition in preparation of emotion-regulating solid beverage 四川科瑞德中领食品有限公司 2023-12-26 CN claimed
CN-105982914-A Novel pharmaceutical composition of compound amino acid injection 18AA-I and application of pharmaceutical composition 刘力 2016-10-05 CN claimed
WO-2008014610-A1 DRUG DELIVERY COMPOSITIONS AND METHODS OF FORMING AND USING SAME MIV THERAPEUTICS INC. (CA) 2008-02-07 WO claimed
CN-119113016-A Solid composition for oral administration and preparation method and application thereof 四川科瑞德食品有限公司 2024-12-13 CN disclosed
CN-119113016-A Solid composition for oral administration and preparation method and application thereof 四川科瑞德食品有限公司 2024-12-13 CN disclosed
CN-118348151-A Method for simultaneously measuring content of total crocin and crocin aldehyde 四川科瑞德食品有限公司 2024-07-16 CN disclosed
CN-117281264-A Emotion-regulating composition, preparation method thereof and application of composition in preparation of emotion-regulating solid beverage 四川科瑞德中领食品有限公司 2023-12-26 CN disclosed
CN-117281264-A Emotion-regulating composition, preparation method thereof and application of composition in preparation of emotion-regulating solid beverage 四川科瑞德中领食品有限公司 2023-12-26 CN disclosed
CN-113019414-B Hydrogenation catalyst, preparation method and application thereof 中国科学院过程工程研究所 2022-10-25 CN disclosed
CN-114828999-A Gas storage materials containing metal-organic structures bound via hydroxamic acids 学校法人立教学院 2022-07-29 CN disclosed
CN-105982914-A Novel pharmaceutical composition of compound amino acid injection 18AA-I and application of pharmaceutical composition 刘力 2016-10-05 CN disclosed
EP-2259773-B1 MACROLIDE COMPOSITIONS HAVING IMPROVED TASTE AND STABILITY PARI PHARMA GMBH (DE) 2013-07-17 EP disclosed
EP-2259773-A1 MACROLIDE COMPOSITIONS HAVING IMPROVED TASTE AND STABILITY PARI Pharma GmbH (DE) 2010-12-15 EP disclosed
US-20090232744-A1 Macrolide compositions having improved taste and stability PARI PHARMA GMBH (DE) 2009-09-17 US disclosed
WO-2009109390-A1 MACROLIDE COMPOSITIONS HAVING IMPROVED TASTE AND STABILITY PARI PHARMA GMBH (DE) 2009-09-11 WO disclosed
EP-2098219-A1 Macrolide compositions having improved taste and stability PARI Pharma GmbH (DE) 2009-09-09 EP disclosed
WO-2008014610-A1 DRUG DELIVERY COMPOSITIONS AND METHODS OF FORMING AND USING SAME MIV THERAPEUTICS INC. (CA) 2008-02-07 WO disclosed